The goal of this clinical trial is to study the effectiveness of a virtual reality-based eye movement desensitization and reprocessing (EMDR) application in treating phobia. It will also learn about the feasibility and safety of the application for independent use. The main questions it aims to answer are: Does the VR EMDR application reduce distress, improve positive cognitions, and decrease avoidance of specific phobias? Can the application help diminish phobia-related bodily sensations and encourage cognitive shifts toward positive beliefs and greater confidence in confronting previously avoided situations? Can the participants independently administer the treatment with minimum assistance? Participants will: Visit the site and take the VR EMDR phobia treatment every day for one week. Report their phobia and simulator sickness symptoms through self-report questionnaires or semi-structured interviews.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Subjective Units of Distress (SUDs)
Timeframe: Recorded 4 times during each VR EMDR session (first being baseline, and the subsequent three were recorded after each eye movement set in desensitisation phrase) across the 5 consecutive intervention days.
Change in Validity of Cognitions (VoC)
Timeframe: Recorded 4 times during each VR EMDR session (first being baseline, and the subsequent three were recorded after each eye movement set in installation phrase) across the 5 consecutive intervention days.
Change in IAPT Phobia Scale Score
Timeframe: Baseline (Day 0, pre-intervention) and post-intervention (Day 5).
The Severity Measure for Specific Phobia-Adult
Timeframe: Baseline (Day 0, pre-intervention) and post-intervention (Day 5).